How can we mitigate treatment-associated morbidity in patients with germ cell tumors?

Volume: 21, Issue: 8, Pages: 805 - 807
Published: Jun 7, 2021
Abstract
Testicular germ cell tumor (GCT) is the most common malignancy in young men [1]. Through a multidisciplinary approach involving surgery, chemotherapy, and radiation, GCTs have cure rates...
Paper Details
Title
How can we mitigate treatment-associated morbidity in patients with germ cell tumors?
Published Date
Jun 7, 2021
Volume
21
Issue
8
Pages
805 - 807
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.